Module 3 2019

Intended Learning Outcomes

• Critical awareness and interpretation of requirements for compiling a 3.2.P Pharmaceutical Development Section of the CTD • Demonstrate a conceptual understanding of data requirements for different dosage forms

The Organisation for Professionals in Regulatory Affairs